Baldea, I.; Moldovan, R.; Nagy, A.-L.; Bolfa, P.; Decea, R.; Miclaus, M.O.; Lung, I.; Gherman, A.M.R.; Sevastre-Berghian, A.; Martin, F.A.;
et al. Ketoconazole-Fumaric Acid Pharmaceutical Cocrystal: From Formulation Design for Bioavailability Improvement to Biocompatibility Testing and Antifungal Efficacy Evaluation. Int. J. Mol. Sci. 2024, 25, 13346.
https://doi.org/10.3390/ijms252413346
AMA Style
Baldea I, Moldovan R, Nagy A-L, Bolfa P, Decea R, Miclaus MO, Lung I, Gherman AMR, Sevastre-Berghian A, Martin FA,
et al. Ketoconazole-Fumaric Acid Pharmaceutical Cocrystal: From Formulation Design for Bioavailability Improvement to Biocompatibility Testing and Antifungal Efficacy Evaluation. International Journal of Molecular Sciences. 2024; 25(24):13346.
https://doi.org/10.3390/ijms252413346
Chicago/Turabian Style
Baldea, Ioana, Remus Moldovan, Andras-Laszlo Nagy, Pompei Bolfa, Roxana Decea, Maria Olimpia Miclaus, Ildiko Lung, Ana Maria Raluca Gherman, Alexandra Sevastre-Berghian, Flavia Adina Martin,
and et al. 2024. "Ketoconazole-Fumaric Acid Pharmaceutical Cocrystal: From Formulation Design for Bioavailability Improvement to Biocompatibility Testing and Antifungal Efficacy Evaluation" International Journal of Molecular Sciences 25, no. 24: 13346.
https://doi.org/10.3390/ijms252413346
APA Style
Baldea, I., Moldovan, R., Nagy, A.-L., Bolfa, P., Decea, R., Miclaus, M. O., Lung, I., Gherman, A. M. R., Sevastre-Berghian, A., Martin, F. A., Kacso, I., & Răzniceanu, V.
(2024). Ketoconazole-Fumaric Acid Pharmaceutical Cocrystal: From Formulation Design for Bioavailability Improvement to Biocompatibility Testing and Antifungal Efficacy Evaluation. International Journal of Molecular Sciences, 25(24), 13346.
https://doi.org/10.3390/ijms252413346
